AcrySof ReSTOR多焦点人工晶状体的临床应用  

Clinical application ofAcrySOF ReSTOR multifocal intraocular lens

作　　者：陈刚[1] 王梦华[1] 袁超峰[1] 

机构地区：[1]郑州大学第四附属医院眼科,郑州450044

出　　处：《中国实用眼科杂志》2009年第6期633-635,共3页Chinese Journal of Practical Ophthalmology

摘　　要：目的观察Acry Sof ReSTOR多焦点人工晶状体的临床应用效果。方法收集2007年5月至2008年1月11例15只眼白内障患者行白内障超声乳化术，并植入Acry Sof ReSTOR SA60D3型多焦点人工晶状体，术后随访6～10个月，定期检查患者的裸眼远、近视力，矫正远、近视力；角膜散光；人工晶状体位置；并以问卷形式调查对不同距离下的视物舒适度、是否存在眩光等视觉症状及戴镜率。结果裸眼及矫正远视力在0．6以上的比例分别为73％和93％，裸眼及矫正近视力Jr3（0．5）以上的比例为67％和80％。80％的患者对术后的视力表示满意。部分病例由于手术切口术后出现散光或散光加重影响视力。73％的患者能不依赖眼镜完成日常活动。结论Acry Sof ReSTOR多焦点人工晶状体能同时提供良好的远、近视力，提高白内障患者术后的生活质量，但手术的高质量和人工晶状体度数的精确计算是术后患者获得满意视力的保证。Objective To evaluate the clinical effect of AcrySOF ReSTOR multifocal intraocular lens （MIOL）. Methods Eleven patients （ 15 eyes） with age related cataract underwent the AcrySof ReSTOR MIOL implantation after phacoemulsification cataract extraction. Uncorrected distance visual acuity （UCDVA）, best-corrected distance visual acuity （BCDVA）, uncorrected near visual acuity （UCNVA）, best-corrected near visual acuity （BCNVA）, corneal astigmatism and IOL place were measured. The questionnaire of visual symptom and the rate of spectacle independence were observed. Results The UCDVA and BCDVA of 0.6 or better were achieved in 73% eyes and 93% eyes. The UCNVA and BCNVA of Jr3 （0.5） or better were achieved in 67% eyes and 80% eyes. About 73% patients never had to wear glasses. Some cases of visual acuity were affected by astigmatism of surgical incision. Conclusion The AcrySof ReSTOR MIOL can provide cataract patients with a full range of quality visionnear, intermediate, and distance, so as to improve the quality of life af- ter surgery, but the high surgical technique and meticulous calculation of IOL power are the key point to obtain excellent visual acuity.

关 键 词：白内障超声乳化摘除术 人工晶状体 多焦点 

分 类 号：R776.1[医药卫生—眼科] R457.1[医药卫生—临床医学]